000			03615nam a22003495i 4500
999			_c76924 _d76924 _x1
001			76924
003			ES-MaUEC
005			20230207040245.0
007			cr nn 008mamaa
008			140421s2014 ne | s |||| 0|eng d
020			_a9789401786577
024	7		_a10.1007/978-94-017-8657-7 _2doi
040			_dES-MaUEC
050		4	_aQH588.S83 _bH473 2014
100	1		_aHescheler, Jürgen _eeditor literario _986323 _0Local
245	1	0	_aAdult and Pluripotent Stem Cells : _bPotential for Regenerative Medicine of the Cardiovascular System _cedited by Jürgen Hescheler, Erhard Hofer
260			_aDordrecht, Netherlands _bSpringer International Publishing _c2014
300			_a1 recurso en línea (XII, 170 p.) _b24 ilustraciones, 22 ilustraciones en color
336			_aTexto (visual) _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_aGeneral Introduction -- The Infarct Cell Therapy (INELPY) consortium -- Mesenchymal stem cells for cardiac repair: preclinical models of disease -- Resident cardiac progenitor cells -- Endothelial progenitor cells derived from cord or peripheral blood and their potential for regenerative therapies -- Adipose-derived stromal/stem cells and their differentiation potential into the endothelial lineage -- Cardiac cell replacement therapy with pluripotent stem cell-derived cardiomyocytes -- Biomaterials for cardiac tissue engineering and regeneration -- Cell therapy of acute myocardial infarction and ischemic cardiomyopathy: from experimental findings to clinical trials -- Clinical gene and stem cell therapy in patients with acute and chronic myocardial ischemia -- Index.
520			_aThere is hardly an area of research developing so quickly and raising so many promises as stem cell research. Adult, embryonic and recently available induced pluripotent stem cells not only foster our understanding of differentiation of endo-, ecto- and mesodermal lineages to all organs of the body, but foremost nourish the hope that cells grown in culture can be used for regeneration of diseased organs such as the heart damaged by myocardial infarction. This book focuses on perspectives of stem cells for regenerative therapy of cardiovascular diseases. Based on the EC consortium INELPY, it reviews the field and disseminates major outcomes of this project. Thus it introduces the reader to this fascinating area of research and incorporates very recent findings interesting to the expert, spanning the field from bench to bedside. The compilation of contributions is unique as there is yet no similar comprehensive overview combining stem cell research with preclinical and clinical evaluation as well as engineering of tissue patches for transplantation. As such it will be an invaluable source of information for all researchers in the stem cell and tissue regeneration field including bioengineers as well as for all clinicians interested in regenerative therapies, especially for ischemic cardiomyopathies.
650		7	_2embne _aCélulas madre _9160528
700	1		_aHofer, Erhard _eeditor literario _986324 _0Local
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-94-017-8657-7 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907			_a.b12825426 _b10-10-17 _c01-10-14
942			_2lcc _cLE
945			_aQH588.S83 H473 2014 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11554630 _z06-04-17
988			_aEBSPRINGER
998			_am _a_alco _a_vill _b - - _cm _dz _e- _feng _gne _h0